Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
| Molecular Weight | 866.9 g/mol |
|---|---|
| Molecular Formula | C42H60Na2O16 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 16 |
| Rotatable Bond Count | 5 |
| Exact Mass | 866.36767439 g/mol |
| Monoisotopic Mass | 866.36767439 g/mol |
| Topological Polar Surface Area | 273 Ų |
| Heavy Atom Count | 60 |
| Formal Charge | 0 |
| Complexity | 1720 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 19 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
ABOUT THIS PAGE
A Disodium Glycyrrhizinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Disodium Glycyrrhizinate, including repackagers and relabelers. The FDA regulates Disodium Glycyrrhizinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Disodium Glycyrrhizinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Disodium Glycyrrhizinate supplier is an individual or a company that provides Disodium Glycyrrhizinate active pharmaceutical ingredient (API) or Disodium Glycyrrhizinate finished formulations upon request. The Disodium Glycyrrhizinate suppliers may include Disodium Glycyrrhizinate API manufacturers, exporters, distributors and traders.
click here to find a list of Disodium Glycyrrhizinate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Disodium Glycyrrhizinate Drug Master File in Japan (Disodium Glycyrrhizinate JDMF) empowers Disodium Glycyrrhizinate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Disodium Glycyrrhizinate JDMF during the approval evaluation for pharmaceutical products. At the time of Disodium Glycyrrhizinate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Disodium Glycyrrhizinate suppliers with JDMF on PharmaCompass.
Disodium Glycyrrhizinate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Disodium Glycyrrhizinate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Disodium Glycyrrhizinate GMP manufacturer or Disodium Glycyrrhizinate GMP API supplier for your needs.
A Disodium Glycyrrhizinate CoA (Certificate of Analysis) is a formal document that attests to Disodium Glycyrrhizinate's compliance with Disodium Glycyrrhizinate specifications and serves as a tool for batch-level quality control.
Disodium Glycyrrhizinate CoA mostly includes findings from lab analyses of a specific batch. For each Disodium Glycyrrhizinate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Disodium Glycyrrhizinate may be tested according to a variety of international standards, such as European Pharmacopoeia (Disodium Glycyrrhizinate EP), Disodium Glycyrrhizinate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Disodium Glycyrrhizinate USP).
LOOKING FOR A SUPPLIER?
